menu
    • menu

    Company profile for Guardant Health

    NEW Drugs in Dev: 2
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics.We believe the key to conquering cancer is unprecedented access to its molecular information throughout all stages of the disease. We are developing a solution through tests that require only a blood sample.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Guardant HealthUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    505 Penobscot Dr. Redwood City, CA 94063
    Telephone
    Telephone
    855.698.8887
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://guardanthealth.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/guardanthealth
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Guardant, Nuvalent partner on cancer diagnostics
    Guardant, Nuvalent partner on cancer diagnostics

    30 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7257152

    FIRSTWORD PHARMA
    30 Apr 2026
    Share Share
    Guardant Health to Report Q1 2026 Results on May 7
    Guardant Health to Report Q1 2026 Results on May 7

    16 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260416881767/en/Guardant-Health-to-Report-First-Quarter-2026-Financial-Results-on-May-7-2026

    BUSINESSWIRE
    16 Apr 2026
    Share Share
    Guardant InfinityAI Supports ENHERTU Approval Japan
    Guardant InfinityAI Supports ENHERTU Approval Japan

    30 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260330846159/en/Guardant-Healths-InfinityAI-Real-World-Evidence-Supports-Approval-of-ENHERTU-for-Previously-Treated-Patients-with-HER2-Positive-Metastatic-Solid-Tumors-in-Japan

    BUSINESSWIRE
    30 Mar 2026
    Share Share
    Verana & Guardant Health Partner For Precision Medicine
    Verana & Guardant Health Partner For Precision Medicine

    24 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/verana-health-and-guardant-health-partner-to-advance-precision-medicine-with-real-world-data-302719285.html

    PR NEWSWIRE
    24 Mar 2026
    Share Share
    Guardant Health To Present 28 Abstracts Highlighting Advances
    Guardant Health To Present 28 Abstracts Highlighting Advances

    18 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260318529389/en/Guardant-Health-to-Present-28-Abstracts-Highlighting-Advances-in-Tumor-Typing-Therapy-Selection-and-Expanded-Utility-of-Multiomic-Tissue-and-Liquid-Biopsy-Testing-at-AACR-2026

    BUSSINESSWIRE
    18 Mar 2026
    Share Share
    Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test
    Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test

    16 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260316025112/en/Guardant-Health-Launches-Shield-Multi-Cancer-Detection-MCD-Test-in-Multiple-Markets-in-Asia-with-Manulife-Partnership

    BUSSINESSWIRE
    16 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search